-
WHO chief lauds India’s assurance to share vaccine production prowess to aid nations fight COVID-19
expresspharma
September 28, 2020
PM Modi had assured that India'sproduction and delivery capacity in vaccines will be used to help all humanity in fighting this crisis at a recent session of the UN General Assembly.
-
Algenex Opens Facility with Capacity to Produce 100 Million Vaccine Doses
americanpharmaceuticalreview
September 27, 2020
Algenex has opened its new facility in Tres Cantos, Spain. The new facility allows Algenex to produce up to 3.5kg of recombinant proteins, equivalent to around 100 million vaccine doses across animal and human health.
-
Government asks States/UTs to establish robust storage mechanism for COVID-19 vaccines
expresspharma
September 27, 2020
It has also requested State/UT authorities to identify the sites for urgent installation of bulk storage cold chain equipment.
-
UK Prime Minister visits the UK Vaccines Manufacturing and Innovation Centre (VMIC)
europeanpharmaceuticalreview
September 22, 2020
Prime Minister Boris Johnson visited the construction site of the VMIC and met scientists and engineers at the forefront of the UK’s COVID-19 response.
-
Why COVID-19 presents a golden opportunity to Indian pharma firms
expresspharma
September 17, 2020
India is among the leaders in the global pharma industry, being the third-largest producer in terms of volume and at the 10th position in terms of value.
-
Which immune response could cause a vaccine against COVID-19?
worldpharmanews
September 15, 2020
Immune reactions caused by vaccination can help protect the organism, or sometimes may aggravate the condition. It is especially important now when multiple vaccines against COVID-19 are being developed.
-
Evotec and Bioaster Partner
contractpharma
September 15, 2020
Evotec SE and Bioaster Technological Research Institute have entered into a partnership to advance research for infectious diseases. Bioaster is a technology and innovation hub located in Lyon, France that has created a new model to address the ...
-
CureVac to Receive €252M to Support COVID-19 Vax Development
contractpharma
September 07, 2020
The German Federal Ministry of Education and Research grant is also expected to be used for the rapid expansion of vaccine production.
-
CureVac expects to produce COVID-19 vaccine at scale by year-end
expresspharma
September 07, 2020
It is one of a number of firms developing vaccines based on molecules carrying a genetic code called messenger RNA (mRNA) to treat diseases.
-
Akers Biosciences, Premas Biotech Announce SARS CoV-2 Positive Proof of Concept Results
americanpharmaceuticalreview
August 28, 2020
Akers Biosciences announced with its partner, Premas Biotech, positive proof of concept results from Animal Studies conducted during a 4 week test of its SARS-CoV-2 vaccine candidate in mice.